Literature DB >> 21331062

Circulating oxidized LDL and inflammation in extreme pediatric obesity.

Anne L Norris1, Julia Steinberger, Lyn M Steffen, Andrea M Metzig, Sarah Jane Schwarzenberg, Aaron S Kelly.   

Abstract

Oxidative stress and inflammation have not been well-characterized in extreme pediatric obesity. We compared levels of circulating oxidized low-density lipoprotein (oxLDL), C-reactive protein (CRP), and interleukin-6 (IL-6) in extremely obese (EO) children to normal weight (NW) and overweight/obese (OW/OB) children. OxLDL, CRP, IL-6, BMI, blood pressure, and fasting glucose, insulin, and lipids were obtained in 225 children and adolescents (age 13.5 ± 2.5 years; boys 55%). Participants were classified into three groups based on gender- and age-specific BMI percentile: NW (<85th, n = 127), OW/OB (85th- <1.2 times the 95th percentile, n = 64) and EO (≥1.2 times the 95th percentile or BMI ≥35 kg/m(2), n = 34). Measures were compared across groups using analysis of covariance, adjusted for gender, age, and race. Blood pressure, insulin, and lipids worsened across BMI groups (all P < 0.0001). OxLDL (NW: 40.8 ± 9.0 U/l, OW/OB: 45.7 ± 12.1 U/l, EO: 63.5 ± 13.8 U/l) and CRP (NW: 0.5 ± 1.0 mg/l, OW/OB: 1.4 ± 2.9 mg/l, EO: 5.6 ± 4.9 mg/l) increased significantly across BMI groups (all groups differed with P < 0.01). IL-6 was significantly higher in EO (2.0 ± 0.9 pg/ml) compared to OW/OB (1.3 ± 1.2 pg/ml, P < 0.001) and NW (1.1 ± 1.0 pg/ml, P < 0.0001) but was not different between NW and OW/OB. Extreme pediatric obesity, compared to milder forms of adiposity and NW, is associated with higher levels of oxidative stress and inflammation, suggesting that markers of early cardiovascular disease and type 2 diabetes mellitus are already present in this young population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331062      PMCID: PMC3684410          DOI: 10.1038/oby.2011.21

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes.

Authors:  Stylianos Kapiotis; Gregor Holzer; Georg Schaller; Markus Haumer; Harald Widhalm; Daniel Weghuber; Bernd Jilma; Georg Röggla; Michael Wolzt; Kurt Widhalm; Oswald F Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-14       Impact factor: 8.311

2.  Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity.

Authors:  Charles Couillard; Guillaume Ruel; W Roodly Archer; Sonia Pomerleau; Jean Bergeron; Patrick Couture; Benoit Lamarche; Nathalie Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2005-09-27       Impact factor: 5.958

3.  The metabolic syndrome and concentrations of C-reactive protein among U.S. youth.

Authors:  Earl S Ford; Umed A Ajani; Ali H Mokdad
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Induction of murine macrophage growth by modified LDLs.

Authors:  S Yui; T Sasaki; A Miyazaki; S Horiuchi; M Yamazaki
Journal:  Arterioscler Thromb       Date:  1993-03

5.  Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study.

Authors:  S R Srinivasan; W Bao; W A Wattigney; G S Berenson
Journal:  Metabolism       Date:  1996-02       Impact factor: 8.694

6.  Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study.

Authors:  David S Freedman; Zuguo Mei; Sathanur R Srinivasan; Gerald S Berenson; William H Dietz
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

7.  Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.

Authors:  Gary P Van Guilder; Greta L Hoetzer; Jared J Greiner; Brian L Stauffer; Christopher A Desouza
Journal:  Obesity (Silver Spring)       Date:  2006-12       Impact factor: 5.002

8.  Inflammatory markers and the risk of coronary heart disease in men and women.

Authors:  Jennifer K Pai; Tobias Pischon; Jing Ma; JoAnn E Manson; Susan E Hankinson; Kaumudi Joshipura; Gary C Curhan; Nader Rifai; Carolyn C Cannuscio; Meir J Stampfer; Eric B Rimm
Journal:  N Engl J Med       Date:  2004-12-16       Impact factor: 91.245

9.  Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women.

Authors:  Tanja Weinbrenner; Helmut Schröder; Veronica Escurriol; Montserrat Fito; Roberto Elosua; Joan Vila; Jaume Marrugat; Maria-Isabel Covas
Journal:  Am J Clin Nutr       Date:  2006-01       Impact factor: 7.045

10.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

Authors:  P Holvoet; J Vanhaecke; S Janssens; F Van de Werf; D Collen
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

View more
  37 in total

1.  Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity.

Authors:  A S Kelly; J R Ryder; K L Marlatt; K D Rudser; T Jenkins; T H Inge
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

2.  Xanthine oxidase and cardiovascular risk in obese children.

Authors:  Harrison K Tam; Aaron S Kelly; Andrea M Metzig; Julia Steinberger; L'Aurelle A Johnson
Journal:  Child Obes       Date:  2014-02-25       Impact factor: 2.992

3.  Severe Obesity in Adolescents and Young Adults Is Associated With Subclinical Cardiac and Vascular Changes.

Authors:  Amy S Shah; Lawrence M Dolan; Philip R Khoury; Zhiqan Gao; Thomas R Kimball; Elaine M Urbina
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

4.  Severe obesity prevalence in 8- to 9-year-old Italian children: a large population-based study.

Authors:  F L Lombardo; A Spinelli; G Lazzeri; A Lamberti; G Mazzarella; P Nardone; V Pilato; M Buoncristiano; M Caroli
Journal:  Eur J Clin Nutr       Date:  2014-09-17       Impact factor: 4.016

5.  Metabolic risk factors in Korean adolescents with severe obesity: Results from the Korea National Health and Nutrition Examination Surveys (K-NHANES) 2007-2014.

Authors:  Won Kyoung Cho; Kyungdo Han; Moon Bae Ahn; Yong-Moon Park; Min Ho Jung; Byung-Kyu Suh; Yong-Gyu Park
Journal:  Diabetes Res Clin Pract       Date:  2018-02-08       Impact factor: 5.602

Review 6.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

7.  The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial.

Authors:  Aaron S Kelly; Kyle D Rudser; Brandon M Nathan; Claudia K Fox; Andrea M Metzig; Brandon J Coombes; Angela K Fitch; Eric M Bomberg; M Jennifer Abuzzahab
Journal:  JAMA Pediatr       Date:  2013-04       Impact factor: 16.193

8.  Impaired cardiac autonomic nervous system function is associated with pediatric hypertension independent of adiposity.

Authors:  Justin R Ryder; Michael O'Connell; Tyler A Bosch; Lisa Chow; Kyle D Rudser; Donald R Dengel; Claudia K Fox; Julia Steinberger; Aaron S Kelly
Journal:  Pediatr Res       Date:  2015-09-21       Impact factor: 3.756

9.  Sex and puberty-related differences in metabolomic profiles associated with adiposity measures in youth with obesity.

Authors:  Christoph Saner; Brooke E Harcourt; Ahwan Pandey; Susan Ellul; Zoe McCallum; Kung-Ting Kao; Celia Twindyakirana; Anke Pons; Erin J Alexander; Richard Saffery; David P Burgner; Markus Juonala; Matthew A Sabin
Journal:  Metabolomics       Date:  2019-05-03       Impact factor: 4.290

Review 10.  Working toward precision medicine approaches to treat severe obesity in adolescents: report of an NIH workshop.

Authors:  Aaron S Kelly; Marsha D Marcus; Jack A Yanovski; Susan Z Yanovski; Stavroula K Osganian
Journal:  Int J Obes (Lond)       Date:  2018-10-03       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.